A Pathway Toward Tumor Cell-Selective CPPs?

Isabel D Alves1, Manon Carré, Solange Lavielle

  • 1Institute of Chemistry & Biology of Membranes & Nanoobjects (UMR5248 CBMN), CNRS, Institut Polytechnique Bordeaux, Universite Bordeaux, All. Geoffroy Saint-Hilaire, 33600, Pessac, France, i.alves@cbmn.u-bordeaux.fr.

Insights

Cell-penetrating peptides (CPPs) can be engineered for cancer cell targeting. Exploiting the enhanced anionic character of tumor cell membranes could improve CPP selectivity for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Cell-penetrating peptides (CPPs) show promise for drug delivery and diagnostics.
  • A major limitation of CPPs is their lack of cell-type specificity.
  • CPPs interact with cell membranes via electrostatic forces with anionic components.

Purpose of the Study:

  • To explore strategies for enhancing CPP selectivity towards cancer cells.
  • To leverage the unique membrane properties of tumor cells for targeted delivery.

Main Methods:

  • Review of existing literature on CPP-cell membrane interactions.
  • Analysis of the role of electrostatic interactions in CPP uptake.
  • Examination of differences in membrane composition between cancer and healthy cells.

Main Results:

  • Tumor cells exhibit overexpression of cell surface glycosaminoglycans.
  • Cancer cell membranes possess a higher proportion of anionic lipids in their outer leaflet.
  • These features result in an increased overall anionic character of tumor cell membranes.

Conclusions:

  • The enhanced anionic nature of cancer cell membranes can be exploited for CPP targeting.
  • This approach offers a potential strategy to improve CPP selectivity for cancer cells.
  • Further research into CPP design based on these membrane properties is warranted.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.8K